Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: Evidence of serotonergic and pro-inflammatory cytokine pathways.

CONCLUSIONS: Combining low dose venlafaxine with an augmenting agent like folic acid, thus, appears to be an optimum strategy to increase its therapeutic efficacy and to reduce its dose. PMID: 26922545 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26922545?dopt=Abstract

Source: Pharmacological Reports - February 29, 2016 Category: Drugs & Pharmacology Authors: Thomas J, Khanam R, Vohora D Tags: Pharmacol Rep Source Type: research